Azzad Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-5,810
| Closed | -$416K | – | 306 |
|
|
2017
Q4 | $416K | Sell |
5,810
-16,737
| -74% | -$1.2M | 0.13% | 219 |
|
|
2017
Q3 | $1.83M | Buy |
22,547
+655
| +3% | +$53.1K | 0.61% | 43 |
|
|
2017
Q2 | $1.55M | Buy |
21,892
+1,222
| +6% | +$86.5K | 0.56% | 44 |
|
|
2017
Q1 | $1.4M | Buy |
20,670
+1,600
| +8% | +$109K | 0.53% | 54 |
|
|
2016
Q4 | $1.37M | Buy |
19,070
+691
| +4% | +$49.5K | 0.56% | 55 |
|
|
2016
Q3 | $1.45M | Buy |
18,379
+3,632
| +25% | +$287K | 0.6% | 51 |
|
|
2016
Q2 | $1.23M | Buy |
14,747
+2,154
| +17% | +$180K | 0.52% | 66 |
|
|
2016
Q1 | $1.16M | Buy |
12,593
+817
| +7% | +$75K | 0.51% | 66 |
|
|
2015
Q4 | $1.19M | Buy |
11,776
+1,049
| +10% | +$106K | 0.57% | 50 |
|
|
2015
Q3 | $1.05M | Buy |
10,727
+1,023
| +11% | +$100K | 0.56% | 57 |
|
|
2015
Q2 | $1.14M | Buy |
9,704
+921
| +10% | +$108K | 0.57% | 52 |
|
|
2015
Q1 | $862K | Buy |
8,783
+4,212
| +92% | +$413K | 0.41% | 104 |
|
|
2014
Q4 | $431K | Buy |
4,571
+251
| +6% | +$23.7K | 0.23% | 176 |
|
|
2014
Q3 | $460K | Buy |
4,320
+196
| +5% | +$20.9K | 0.27% | 150 |
|
|
2014
Q2 | $342K | Buy |
4,124
+26
| +0.6% | +$2.16K | 0.21% | 208 |
|
|
2014
Q1 | $290K | Buy |
4,098
+281
| +7% | +$19.9K | 0.19% | 221 |
|
|
2013
Q4 | $287K | Buy |
3,817
+322
| +9% | +$24.2K | 0.21% | 200 |
|
|
2013
Q3 | $220K | Hold |
3,495
| – | – | 0.18% | 211 |
|
|
2013
Q2 | $220K | Buy |
+3,495
| New | +$220K | 0.19% | 208 |
|